TY - JOUR
T1 - Indeterminate melanocytic proliferations of the conjunctiva
AU - Grossiiijelaus, Hans E.
AU - Margo, Ciirüs E.
AU - Solomon, Alvin R.
PY - 1999/9
Y1 - 1999/9
N2 - Objective: To test the hypothesis that a subset of conjunctival melanocytic proliferations exists that cannot be reproducibly classified as benign, malignant, or indeterminate. Methods: Three groups of excisional biopsy specimens of conjunctival melanocytic proliferations were evaluated by a panel of 5 ophthalmic pathologists. These groups included lesions that we considered to represent benign (group 1 [n = 5]), malignant (group 2 [n = 5]), and indeterminate melanocytic proliferations (group 3 [n = 5]). The panel classified the same sections in all 3 groups in a randomized, masked fashion, first without and then with a clinical history of patient age, sex, and race. The κ statistic was used to quantify the degree of agreement among observers. Results: There was strong concordance among the panel members for both group 1 (benign [κ = 0.76]) and group 2 (malignant [κ = 0.70]) melanocytic proliferations. There was no concordance of the panel for group 3 (indeterminate) lesions (κ = -0.045). The concordance for groups 1 and 2 and lack of concordance for group 3 lesions were independent of knowledge of clinical history of age, sex, and race. Conclusion: A subset of melanocytic proliferations of the conjunctiva exists that cannot be reproducibly classified by pathologists as benign, malignant, or indeterminate.
AB - Objective: To test the hypothesis that a subset of conjunctival melanocytic proliferations exists that cannot be reproducibly classified as benign, malignant, or indeterminate. Methods: Three groups of excisional biopsy specimens of conjunctival melanocytic proliferations were evaluated by a panel of 5 ophthalmic pathologists. These groups included lesions that we considered to represent benign (group 1 [n = 5]), malignant (group 2 [n = 5]), and indeterminate melanocytic proliferations (group 3 [n = 5]). The panel classified the same sections in all 3 groups in a randomized, masked fashion, first without and then with a clinical history of patient age, sex, and race. The κ statistic was used to quantify the degree of agreement among observers. Results: There was strong concordance among the panel members for both group 1 (benign [κ = 0.76]) and group 2 (malignant [κ = 0.70]) melanocytic proliferations. There was no concordance of the panel for group 3 (indeterminate) lesions (κ = -0.045). The concordance for groups 1 and 2 and lack of concordance for group 3 lesions were independent of knowledge of clinical history of age, sex, and race. Conclusion: A subset of melanocytic proliferations of the conjunctiva exists that cannot be reproducibly classified by pathologists as benign, malignant, or indeterminate.
UR - http://www.scopus.com/inward/record.url?scp=0032869702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032869702&partnerID=8YFLogxK
U2 - 10.1001/archopht.117.9.1131
DO - 10.1001/archopht.117.9.1131
M3 - Article
C2 - 10496383
AN - SCOPUS:0032869702
SN - 2168-6165
VL - 117
SP - 1131
EP - 1136
JO - JAMA Ophthalmology
JF - JAMA Ophthalmology
IS - 9
ER -